4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-23-000099
Options or other derivatives
- Chief Business Officer acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Boyle Scott N · Chief Business Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-18 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +120,000 | 120,000 | D |
Loading xslF345X05/wk-form4_1695165770.xml…